ProCE Banner Activity


Clinical Application of New Advances in Metastatic Prostate Cancer: Education and Resources for Oncology Nurses

Watch this on-demand webcast featuring nursing expert insights on best practices for care of patients with metastatic prostate cancer, including treatment selection in the settings of hormone-sensitive and castration-resistant disease, managing treatment-related adverse events, and important clinical trials.

Nurses: 0.75 Nursing contact hour, including 0.75 hour of pharmacotherapy credit 

Released: November 03, 2022

Expiration: November 02, 2023

No longer available for credit.



Brenda Martone

Brenda Martone, MSN, ANP-BC, AOCNP

Nurse Practitioner
Department of GU Oncology
Northwestern Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner


Supported by educational grants from

Janssen administered by Scientific Affairs

Novartis Pharmaceuticals Corporation

Sanofi Genzyme

Target Audience

This program is intended for oncology nurses and other HCPs who care for patients with prostate cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Discuss with patients the current evidence-based treatment and supportive care options available for metastatic castration-sensitive and castration-resistant prostate cancer
  • Effectively communicate to colleagues and patients the rationale for PARP inhibitor–based regimens in metastatic prostate cancer in tumors with or without DNA damage repair alterations
  • Counsel patients on the administration and management of unique toxicities associated with targeted therapies
  • Develop a proactive management plan to support adherence in patients receiving oral therapies
  • Identify patients suitable for enrollment on ongoing clinical studies investigating combination regimens in metastatic prostate cancer


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Brenda Martone, MSN, ANP-BC, AOCNP

Nurse Practitioner
Department of GU Oncology
Northwestern Medicine
Chicago, Illinois

Brenda Martone, MSN, ANP-BC, AOCNP, has no relevant financial relationships to disclose.

Staff Disclosure


Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant financial relationships to disclose.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no relevant financial relationships to disclose.

Krista Marcello,

Associate Managing Editor

Krista Marcello has no relevant financial relationships to disclose.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no relevant financial relationships to disclose.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no relevant financial relationships to disclose.

Justine Stanley, MSc

Editorial Contributor

Justine Stanley has no relevant financial relationships to disclose.

Instructions for Credit


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 03, 2022, through November 02, 2023:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


The goal of this activity is to improve oncology nurses’ ability to educate and optimally care for patients with prostate cancer.